104 related articles for article (PubMed ID: 7923102)
1. Anti-proliferative activity of interferon-alpha on human squamous carcinoma of tongue cell lines.
King WW; Lam PK; Li AK
Cancer Lett; 1994 Sep; 85(1):55-8. PubMed ID: 7923102
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative effects of cytokines on squamous cell carcinoma.
Sacchi M; Klapan I; Johnson JT; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1991 Mar; 117(3):321-6. PubMed ID: 1900161
[TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of head and neck cancer-cell growth by human recombinant interferon-alpha and 13-cis retinoic acid.
Lam PK; To EW; Chan ES; Liew CT; Lung IW; King WK
Br J Biomed Sci; 2001; 58(4):226-9. PubMed ID: 11787998
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
Hussain M; Benedetti J; Smith RE; Rodriguez GI; Schuller D; Ensley J
Cancer; 1995 Oct; 76(7):1233-7. PubMed ID: 8630903
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor and chemotherapeutic agents. Potentiation of cytotoxicity with interferon gamma.
Dawson DE; Gapany M; Burgess RC; Boesen PV; Headley DB
Arch Otolaryngol Head Neck Surg; 1992 Nov; 118(11):1168-71. PubMed ID: 1418895
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a human cell line from a squamous carcinoma of the tongue.
King WW; Lam PK; Huang DW; Liew CT; Li AK
Clin Otolaryngol Allied Sci; 1995 Feb; 20(1):15-20. PubMed ID: 7788927
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines.
Schiller JH; Bittner G
Int J Cancer; 1990 Jul; 46(1):61-6. PubMed ID: 2114374
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer.
Furusaka T; Asakawa T; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2012 Oct; 132(10):1108-14. PubMed ID: 22998559
[TBL] [Abstract][Full Text] [Related]
10. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K
Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid and interferon alpha act synergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma.
Lingen MW; Polverini PJ; Bouck NP
Cancer Res; 1998 Dec; 58(23):5551-8. PubMed ID: 9850093
[TBL] [Abstract][Full Text] [Related]
12. Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
Etienne MC; Bernard S; Fischel JL; Formento P; Gioanni J; Santini J; Demard F; Schneider M; Milano G
Br J Cancer; 1991 Mar; 63(3):372-7. PubMed ID: 2003979
[TBL] [Abstract][Full Text] [Related]
13. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
[TBL] [Abstract][Full Text] [Related]
14. [Synergistic effects of human tumor necrosis factor-alpha gene transfection and interferon-gamma on the growth of tongue carcinoma cells].
Gao Z; Li S; Gao J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2002 Feb; 20(1):55-7. PubMed ID: 12593205
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
Losinno C; Wines BD; Johns TG; Mackay IR
Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation of lines derived from human cervical carcinomas by cytotoxic drugs and by recombinant interferons.
Jacobs AJ; Dawoud L; Kovacs Z; Ratliff TL
Gynecol Oncol; 1989 Jan; 32(1):31-6. PubMed ID: 2491828
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
[TBL] [Abstract][Full Text] [Related]
18. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
Ohmura K; Tsukamoto T
Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
20. Antiepidermal growth factor receptor antibodies augment cytotoxicity of chemotherapeutic agents on squamous cell carcinoma cell lines.
Brown D; Wang R; Russell P
Otolaryngol Head Neck Surg; 2000 Jan; 122(1):75-83. PubMed ID: 10629487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
